| Jul 18 |
Ardelyx, Groups File Lawsuit Over Dialysis Payment System Coverage
|
| Jul 18 |
Ardelyx to Report Second Quarter 2024 Financial Results on August 1, 2024
|
| Jul 17 |
Ardelyx, AAKP and NMQF File Lawsuit to Protect Dialysis Patient Choice and Timely Access to Clinically Meaningful Medicines
|
| Jul 15 |
Enanta Pharmaceuticals (ENTA) Soars 6.7%: Is Further Upside Left in the Stock?
|
| Jul 13 |
Ardelyx: Increased Focus On Ibsrela Due To Xphozah's Uncertain Outlook
|
| Jul 2 |
Ardelyx stock tumbles 20% on CMS payment update
|
| Jul 2 |
To Preserve Patient Access to XPHOZAH®, Ardelyx Chooses Not to File for TDAPA
|
| Jun 28 |
Ardelyx Presents Additional Data Detailing Educational Needs Related to IBS-C Management Across Healthcare Disciplines
|
| Jun 27 |
Ardelyx: Potential Headwinds From Weight-Loss Drug Advancements
|
| Jun 22 |
When Will Ardelyx, Inc. (NASDAQ:ARDX) Become Profitable?
|
